CL-2022-000676 - [2025] EWHC 2486 (Comm)
Commercial Court

CL-2022-000676 - [2025] EWHC 2486 (Comm)

Fecha: 01-Oct-2025

The Contractual Claim

The Contractual Claim

Introduction

175.

The basic principles of construction do not need extensive discussion. As is to be expected, reference was made to the current core trinity of cases: Rainy Sky SA v Kookmin Bank[2011] UKSC 50 at [21] (per Lord Clarke), Arnold v Britton [2015] UKSC 36; [2015] 2 WLR 1593 at [15]-[23] (Lord Neuberger) & [76]-[77] (Lord Hodge) and Wood v Capita Insurance Services Limited[2017] UKSC 24 at [9]-[15]. A little variety was offered by reference to useful summaries by HHJ Pelling KC and approved by the Vos C in Lamesa Investments Ltd v Cynergy Bank Ltd [2020] EWCA Civ 821, 2021 2 All ER (Comm) 573 at [18] and ABC Electrification Limited v Network Rail Infrastructure Limited [2020] EWCA Civ 1645, at [18 (ii)].

176.

However the issues between the parties did not require reference to these principles, but were more about how the specific contractual structure worked and which bits, if any, required to be read down.

177.

There are a number of points of construction which are in dispute. These can be summarised thus:

a.

Did the Contract require Medpro to follow a validated process demonstrating that the gowns when delivered should be sterile to a sterility assurance level (SAL) of 10-6;

b.

Did the Contract require Medpro to follow a process, consisting either of the application of BS EN 556-1:2001 or an “equivalent technical solution” to the manufacture and sterilisation of the gowns?

c.

Did the Contract require Medpro either to apply a valid CE mark to the gowns, or to have obtained a derogation pursuant to Regulation 12(5) of the Medical Devices Regulations 2002 (“MDR 2002”) for the gowns?

178.

It is fair to say that the first of these issues has only taken full form during the course of trial. However it was not, at least initially, suggested that this question was not capable of being fairly decided based on the evidence which was before the Court. While Medpro in closing somewhat resiled from its earlier acceptance of the issue as live, it is, though unpleaded, a point which was squarely raised by the start of trial and would have been explicitly pleaded had Medpro objected earlier. In addition (and as reflected by Medpro’s initial reaction to it) it is not an issue which would have caused prejudice such as to make it appropriate to shut the issue out. Accordingly that issue is considered below.